natgillin/translations-raw huggingface dataset:
1-[4-(3-amino-1H-indazol-4-yl)phenyl]-3-(2-fluor-5-methylphenyl)urea
1-[4-(3-amino-1H-indazol-4-yl)phenyl]-3-(2-fluoro-5-methylphenyl)urea
1-[4-(3-amino-1H-indazol-4-yl)phenyl]-3-(2-fluor-5-methylphenyl)ureahydrochlorid
1-[4-(3-amino-1H-indazol-4-yl)phenyl]-3-(2-fluoro-5-methylphenyl)urea hydrochloride
2-[(2R)-2-methylpyrrolidin-2-yl]-1H-benzimidazol-4-carboxamid
2-[(2R)-2-methylpyrrolidin-2-yl]-1H-benzimidazole-4-carboxamide
2-[(2S)-2-methylpyrrolidin-2-yl]-1H-benzimidazol-4-carboxamiddihydrochlorid
2-[(2S)-2-methylpyrrolidin-2-yl]-1H-benzimidazole-4-carboxamide dihydrochloride
3,3-difluorpyrrolidinhydrochlorid
3,3-difluoropyrrolidine hydrochloride
3-5-[(2R)-2-aminopropyl]-7-cyan-2,3-dihydro-1H-indol-1-ylpropylbenzoat-(2R,3R)-2,3-dihydroxybutandioat
3-5-[(2R)-2-aminopropyl]-7-cyano-2,3-dihydro-1H-indol-1-ylpropyl benzoate (2R,3R)-2,3-dihydroxybutanedioate
3-oxo-3,4-dihydropyrazin-2-carboxamid
3-oxo-3,4-dihydropyrazine-2-carboxamide
4-[(4-fluor-2-methyl-1H-indol-5-yl)oxy]-5-methylpyrrolo[2,1-f][1,2,4]triazin-6-yl 2,2-dimethylpropanoat
4-[(4-fluoro-2-methyl-1H-indol-5-yl)oxy]-5-methylpyrrolo[2,1-f][1,2,4]triazin-6-yl 2,2-dimethylpropanoate
4-amino-8-(2,5-dimethoxyphenyl)-N-propylcinnolin-3-carboxamid
4-amino-8-(2,5-dimethoxyphenyl)-N-propylcinnoline-3-carboxamide
4-amino-8-(2-fluor-6-methoxyphenyl)-N-propylcinnolin-3-carboxamid
4-amino-8-(2-fluoro-6-methoxyphenyl)-N-propylcinnoline-3-carboxamide
5-(2-chlor-6-fluorphenyl)-2H-tetrazol
5-(2-chloro-6-fluorophenyl)-2H-tetrazole
5-(4-chlorbutyl)-1-cyclohexyl-1H-tetrazol
5-(4-chlorobutyl)-1-cyclohexyl-1H-tetrazole
5-[(4-brom-2-chlorphenyl)amino]-4-fluor-N-(2-hydroxyethoxy)-1-methyl-1H-benzimidazol-6-carboxamid
5-[(4-bromo-2-chlorophenyl)amino]-4-fluoro-N-(2-hydroxyethoxy)-1-methyl-1H-benzimidazole-6-carboxamide
5-fluor-1-(3-fluorbenzyl)-N-(1H-indol-5-yl)-1H-indol-2-carboxamid
5-fluoro-1-(3-fluorobenzyl)-N-(1H-indol-5-yl)-1H-indole-2-carboxamide
5-methyl-4-oxo-1,4-dihydropyrrolo[2,1-f][1,2,4]triazin-6-yl-2,2-dimethylpropanoat
5-methyl-4-oxo-1,4-dihydropyrrolo[2,1-f][1,2,4]triazin-6-yl 2,2-dimethylpropanoate
6-brom-3-oxo-3,4-dihydropyrazin-2-carboxamid
6-bromo-3-oxo-3,4-dihydropyrazine-2-carboxamide
6-fluor-3-oxo-3,4-dihydropyrazin-2-carbonitril – N-cyclohexylcyclohexanamin (1:1)
6-fluoro-3-oxo-3,4-dihydropyrazine-2-carbonitrile – N-cyclohexylcyclohexanamine (1:1)
6-iod-1H-indazol
6-iodo-1H-indazole
8,9-difluor-5-methyl-1-oxo-6,7-dihydro-1H,5H-pyrido[3,2,1-ij]quinolin-2-carboxylsyre
8,9-difluoro-5-methyl-1-oxo-6,7-dihydro-1H,5H-pyrido[3,2,1-ij]quinoline-2-carboxylic acid
benzyl-(2S,3aR,7aS)-octahydro-1H-indol-2-carboxylathydrochlorid
benzyl (2S,3aR,7aS)-octahydro-1H-indole-2-carboxylate hydrochloride
benzyl-(2S,3aS,6aS)-octahydrocyclopenta[b]pyrrol-2-carboxylathydrochlorid
benzyl (2S,3aS,6aS)-octahydrocyclopenta[b]pyrrole-2-carboxylate hydrochloride
ethyl-2-amino-9,10-dimethoxy-1,6,7,11b-tetrahydro-4H-pyrido[2,1-a]isoquinolin-3-carboxylat
ethyl 2-amino-9,10-dimethoxy-1,6,7,11b-tetrahydro-4H-pyrido[2,1-a]isoquinoline-3-carboxylate
ethyl-6-brom-5-hydroxy-1-methyl-2-[(phenylsulfanyl)methyl]-1H-indol-3-carboxylat
ethyl 6-bromo-5-hydroxy-1-methyl-2-[(phenylsulfanyl)methyl]-1H-indole-3-carboxylate
ethyl-7-(3-aminopyrrolidin-1-yl)-1-(2,4-difluorphenyl)-6-fluor-4-oxo-1,4-dihydro-1,8-naphthyridin-3-carboxylat
ethyl 7-(3-aminopyrrolidin-1-yl)-1-(2,4-difluorophenyl)-6-fluoro-4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxylate
methyl-1-[(2′-cyanbiphenyl-4-yl)methyl]-2-ethoxy-1H-benzimidazol-7-carboxylat
methyl 1-[(2′-cyanobiphenyl-4-yl)methyl]-2-ethoxy-1H-benzimidazole-7-carboxylate
methyl-1-tert-butyl-2-hydroxy-1H-pyrrolo[2,3-b]pyridin-3-carboxylat
methyl 1-tert-butyl-2-hydroxy-1H-pyrrolo[2,3-b]pyridine-3-carboxylate
N2-[(benzyloxy)carbonyl]-L-glutaminyl-L-asparaginyl-S-benzyl-L-cysteinyl-L-prolyl-L-leucylglycinamid
N2-[(benzyloxy)carbonyl]-L-glutaminyl-L-asparaginyl-S-benzyl-L-cysteinyl-L-prolyl-L-leucylglycinamide
tert-butyl-(1S,3S,5S)-3-carbamoyl-2-azabicyclo[3.1.0]hexan-2-carboxylat
tert-butyl (1S,3S,5S)-3-carbamoyl-2-azabicyclo[3.1.0]hexane-2-carboxylate
tert-butyl-(2S)-2-carbamoyl-2,3-dihydro-1H-pyrrol-1-carboxylat
tert-butyl (2S)-2-carbamoyl-2,3-dihydro-1H-pyrrole-1-carboxylate
tert-butyl-[(1S)-2-[(1S,3S,5S)-3-cyan-2-azabicyclo[3.1.0]hex-2-yl]-1-(3-hydroxytricyclo[3.3.1.1(3,7)]dec-1-yl)-2-oxoethyl]carbamat
tert-butyl [(1S)-2-[(1S,3S,5S)-3-cyano-2-azabicyclo[3.1.0]hex-2-yl]-1-(3-hydroxytricyclo[3.3.1.1(3,7)]dec-1-yl)-2-oxoethyl]carbamate
methyl-2-((R)-3-(3-((E)-2-(7-chlorquinolin-2-yl)vinyl)phenyl)-3-(((1-(hydroxymethyl)cyclopropyl)methyl)sulfanyl)propyl)benzoat
methyl 2-((R)-3-(3-((E)-2-(7-chloroquinolin-2-yl)vinyl)phenyl)-3-(((1-(hydroxymethyl)cyclopropyl)methyl)sulfanyl)propyl)benzoate
(2Z)-[(acetyloxy)imino](2-amino-1,3-thiazol-4-yl)ethansyre
(2Z)-[(acetyloxy)imino](2-amino-1,3-thiazol-4-yl)ethanoic acid
(2Z)-[(1-tert-butoxy-2-methyl-1-oxopropan-2-yl)oxy]imino[2-(tritylamino)-1,3-thiazol-4-yl]ethansyre
(2Z)-[(1-tert-butoxy-2-methyl-1-oxopropan-2-yl)oxy]imino[2-(tritylamino)-1,3-thiazol-4-yl]ethanoic acid
(5Z)-5-(4-fluorbenzyliden)-1,3-thiazolidin-2,4-dion
(5Z)-5-(4-fluorobenzylidene)-1,3-thiazolidine-2,4-dione
2-amino-N-(2-chlor-6-methylphenyl)-1,3-thiazol-5-carboxamid
2-amino-N-(2-chloro-6-methylphenyl)-1,3-thiazole-5-carboxamide
3-[2-chlor-4-(4-methyl-2-[4-(trifluormethyl)phenyl]-1,3-thiazol-5-ylmethoxy)phenyl]-1,2,4-oxadiazol-5(4H)-on
3-[2-chloro-4-(4-methyl-2-[4-(trifluoromethyl)phenyl]-1,3-thiazol-5-ylmethoxy)phenyl]-1,2,4-oxadiazol-5(4H)-one
4-(2-chlor-4-methoxy-5-methylphenyl)-N-[(1S)-2-cyclopropyl-1-(3-fluor-4-methylphenyl)ethyl]-5-methyl-N-(prop-2-yn-1-yl)-1,3-thiazol-2-amin
4-(2-chloro-4-methoxy-5-methylphenyl)-N-[(1S)-2-cyclopropyl-1-(3-fluoro-4-methylphenyl)ethyl]-5-methyl-N-(prop-2-yn-1-yl)-1,3-thiazol-2-amine
L-lysin – [(2R,3R)-3-[4-(4-cyanphenyl)-1,3-thiazol-2-yl]-2-(2,4-difluorphenyl)-1-(1H-1,2,4-triazol-1-yl)butan-2-yl]oxymethyldihydrogenphosphat – ethanol (1:1:1)
L-lysine – [(2R,3R)-3-[4-(4-cyanophenyl)-1,3-thiazol-2-yl]-2-(2,4-difluorophenyl)-1-(1H-1,2,4-triazol-1-yl)butan-2-yl]oxymethyl dihydrogen phosphate – ethanol (1:1:1)
N-(2-chlor-6-methylphenyl)-2-[(6-chlor-2-methylpyrimidin-4-yl)amino]-1,3-thiazol-5-carboxamid
N-(2-chloro-6-methylphenyl)-2-[(6-chloro-2-methylpyrimidin-4-yl)amino]-1,3-thiazole-5-carboxamide
natrium-(2Z)-(2-amino-1,3-thiazol-4-yl)(hydroxyimino)ethanoat
sodium (2Z)-(2-amino-1,3-thiazol-4-yl)(hydroxyimino)ethanoate
(1-benzothiophen-5-yl)eddikesyre
(1-benzothiophen-5-yl)acetic acid
(2R)-3′H-spiro[4-azabicyclo[2.2.2]octan-2,2′-furo[2,3-b]pyridin]
(2R)-3′H-spiro[4-azabicyclo[2.2.2]octane-2,2′-furo[2,3-b]pyridine]
(2R)-3′H-spiro[4-azabicyclo[2.2.2]octan-2,2′-furo[2,3-b]pyridin] (S,S)-2,3-dihydroxybutandioat
(2R)-3′H-spiro[4-azabicyclo[2.2.2]octane-2,2′-furo[2,3-b]pyridine] (S,S)-2,3-dihydroxybutanedioate
(2R,3R,4R,5R)-2-(4-amino-5-fluor-2-oxopyrimidin-1(2H)-yl)-2-fluor-5-methyltetrahydrofuran-3,4-diyldiacetat
(2R,3R,4R,5R)-2-(4-amino-5-fluoro-2-oxopyrimidin-1(2H)-yl)-2-fluoro-5-methyltetrahydrofuran-3,4-diyl diacetate
(2R,3S,4R)-5-(4-amino-2-oxopyrimidin-1(2H)-yl)-2-azido-2-[(2-methylpropanoyl)oxy]methyltetrahydrofuran-3,4-diylbis(2-methylpropanoat)hydrochlorid
(2R,3S,4R)-5-(4-amino-2-oxopyrimidin-1(2H)-yl)-2-azido-2-[(2-methylpropanoyl)oxy]methyltetrahydrofuran-3,4-diyl bis(2-methylpropanoate) hydrochloride
(3-[(2R,3S)-2-(1R)-1-[3,5-bis(trifluormethyl)phenyl]ethoxy-3-(2-fluorphenyl)morpholin-4-yl]methyl-5-oxo-2,5-dihydro-1H-1,2,4-triazol-1-yl)phosphonsyre – 1-deoxy-1-(methylamino)-D-glucitol (1:2)
(3-[(2R,3S)-2-(1R)-1-[3,5-bis(trifluoromethyl)phenyl]ethoxy-3-(2-fluorophenyl)morpholin-4-yl]methyl-5-oxo-2,5-dihydro-1H-1,2,4-triazol-1-yl)phosphonic acid – 1-deoxy-1-(methylamino)-D-glucitol (1:2)
(3S)-10-[1-(acetylamino)cyclopropyl]-9-fluor-3-methyl-7-oxo-2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinolin-6-carboxylsyre
(3S)-10-[1-(acetylamino)cyclopropyl]-9-fluoro-3-methyl-7-oxo-2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid
(3S)-N,N-dimethyl-3-(naphthalen-1-yloxy)-3-(thiophen-2-yl)propan-1-amin
(3S)-N,N-dimethyl-3-(naphthalen-1-yloxy)-3-(thiophen-2-yl)propan-1-amine
(3S,6R,9S,12R,15S,18R,21S,24R)-6,18-dibenzyl-4,10,12,16,22,24-hexamethyl-3,9,15,21-tetrakis(2-methylpropyl)-1,7,13,19-tetraoxa-4,10,16,22-tetraazacyclotetracosan-2,5,8,11,14,17,20,23-octon
(3S,6R,9S,12R,15S,18R,21S,24R)-6,18-dibenzyl-4,10,12,16,22,24-hexamethyl-3,9,15,21-tetrakis(2-methylpropyl)-1,7,13,19-tetraoxa-4,10,16,22-tetraazacyclotetracosane-2,5,8,11,14,17,20,23-octone
(6R)-6-cyclopentyl-6-[2-(2,6-diethylpyridin-4-yl)ethyl]-3-[(5,7-dimethyl[1,2,4]triazolo[1,5-a]pyrimidin-2-yl)methyl]-4-hydroxy-5,6-dihydro-2H-pyran-2-on
(6R)-6-cyclopentyl-6-[2-(2,6-diethylpyridin-4-yl)ethyl]-3-[(5,7-dimethyl[1,2,4]triazolo[1,5-a]pyrimidin-2-yl)methyl]-4-hydroxy-5,6-dihydro-2H-pyran-2-one
(2R,3S,4R,5R)-2-azido-5-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-3,4-bis[(phenylcarbonyl)oxy]tetrahydrofuran-2-ylmethyl 3-chlorbenzoat
(2R,3S,4R,5R)-2-azido-5-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-3,4-bis[(phenylcarbonyl)oxy]tetrahydrofuran-2-ylmethyl 3-chlorobenzoate
1-(1-4-[2-(4-fluorphenyl)-1,3-dioxolan-2-yl]butyl-1,2,3,6-tetrahydropyridin-4-yl)-1,3-dihydro-2H-benzimidazol-2-on
1-(1-4-[2-(4-fluorophenyl)-1,3-dioxolan-2-yl]butyl-1,2,3,6-tetrahydropyridin-4-yl)-1,3-dihydro-2H-benzimidazol-2-one
1-[(2R,5S)-5-(hydroxymethyl)-2,5-dihydrofuran-2-yl]-5-methylpyrimidin-2,4(1H,3H)-dion – 1-methylpyrrolidin-2-on (1:1)
1-[(2R,5S)-5-(hydroxymethyl)-2,5-dihydrofuran-2-yl]-5-methylpyrimidine-2,4(1H,3H)-dione – 1-methylpyrrolidin-2-one (1:1)
1-[3-(2-benzo[b]thien-5-ylethoxy)propyl]-3-azetidinol – (2Z)-2-butendioat (1:1)
1-[3-(2-benzo[b]thien-5-ylethoxy)propyl]-3-azetidinol – (2Z)-2-butenedioate (1:1)
1-[(2R,3S)-2-(2,4-difluorphenyl)-3-methyloxiran-2-yl]methyl-1H-1,2,4-triazol
1-[(2R,3S)-2-(2,4-difluorophenyl)-3-methyloxiran-2-yl]methyl-1H-1,2,4-triazole
2-([(1R,3S)-3-[2-(3-methoxyphenyl)-5-methyl-1,3-oxazol-4-yl]methoxycyclohexyl]oxymethyl)-6-methylbenzoesyre
2-([(1R,3S)-3-[2-(3-methoxyphenyl)-5-methyl-1,3-oxazol-4-yl]methoxycyclohexyl]oxymethyl)-6-methylbenzoic acid
2-[(4-[(2,2-dimethyl-1,3-dioxan-5-yl)methoxy]-3,5-dimethylpyridin-2-ylmethyl)sulfinyl]-1H-benzimidazol, natriumsalt (1:1)
2-[(4-[(2,2-dimethyl-1,3-dioxan-5-yl)methoxy]-3,5-dimethylpyridin-2-ylmethyl)sulfinyl]-1Hbenzimidazole, sodium salt (1:1)
2-[(3aR,4S,6R,6aS)-6-[5-amino-6-chlor-2-(propylsulfanyl)pyrimidin-4-yl]amino-2,2-dimethyltetrahydro-3aH-cyclopenta[d][1,3]dioxol-4-yl]oxyethanol
2-[(3aR,4S,6R,6aS)-6-[5-amino-6-chloro-2-(propylsulfanyl)pyrimidin-4-yl]amino-2,2-dimethyltetrahydro-3aH-cyclopenta[d][1,3]dioxol-4-yl]oxyethanol
2-brom-1-[3-tert-butyl-4-methoxy-5-(morpholin-4-yl)phenyl]ethanon
2-bromo-1-[3-tert-butyl-4-methoxy-5-(morpholin-4-yl)phenyl]ethanone
3-(5-[4-(cyclopentyloxy)-2-hydroxyphenyl]carbonyl-2-[(3-hydroxy-1,2-benzoxazol-6-yl)methoxy]phenyl)propansyre
3-(5-[4-(cyclopentyloxy)-2-hydroxyphenyl]carbonyl-2-[(3-hydroxy-1,2-benzoxazol-6-yl)methoxy]phenyl)propanoic acid
3-[2-(1-benzothiophen-5-yl)ethoxy]propionsyre
3-[2-(1-benzothiophen-5-yl)ethoxy]propionic acid
3-oxo-4-(2,3,5-tri-O-acetyl-β-D-ribofuranosyl)-3,4-dihydropyrazin-2-carboxamid
3-oxo-4-(2,3,5-tri-O-acetyl-β-D-ribofuranosyl)-3,4-dihydropyrazine-2-carboxamide
3-oxo-4-(β-D-ribofuranosyl)-3,4-dihydropyrazin-2-carboxamid
3-oxo-4-(β-D-ribofuranosyl)-3,4-dihydropyrazine-2-carboxamide
4-[3-hydroxy-3-phenyl-3-(thiophen-2-yl)propyl]-4-methylmorpholin-4-iummethylsulfat
4-[3-hydroxy-3-phenyl-3-(thiophen-2-yl)propyl]-4-methylmorpholin-4-ium methyl sulfate
4-[4-(3-[(4-deoxy-4-fluor-b-D-glucopyranosyl)oxy]-5-(propan-2-yl)-1H-pyrazol-4-ylmethyl)phenyl]-N-[1,3-dihydroxy-2-(hydroxymethyl)propan-2-yl]butanamid
4-[4-(3-[(4-deoxy-4-fluoro-b-D-glucopyranosyl)oxy]-5-(propan-2-yl)-1H-pyrazol-4-ylmethyl)phenyl]-N-[1,3-dihydroxy-2-(hydroxymethyl)propan-2-yl]butanamide
4-nitrobenzyl(6R,7R)-7-amino-8-oxo-3-[(2S)-tetrahydrofuran-2-yl]-5-thia-1-azabicyclo[4.2.0]oct-2-en-2-carboxylathydrochlorid
4-nitrobenzyl(6R,7R)-7-amino-8-oxo-3-[(2S)-tetrahydrofuran-2-yl]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate hydrochloride
5,7-dioxa-6-thiaspiro[2.5]octan-6-oxid
5,7-dioxa-6-thiaspiro[2.5]octane-6-oxide
5-[4-[[3-chlor-4-[(3-fluorphenyl)methoxy]phenyl]amino]-6-quinazolinyl]-2-furancarboxaldehyd – 4-methylbenzensulfonat (1:1)
5-[4-[[3-chloro-4-[(3-fluorophenyl)methoxy]phenyl]amino]-6-quinazolinyl]-2-furancarboxaldehyde – 4-methylbenzenesulfonate (1:1)
5-brom-1-benzothiophen
5-bromo-1-benzothiophene
6-(brommethyl)-2-triphenylmethyl-1,2-benzisoxazol-3(2H)-on
6-(bromomethyl)-2-triphenylmethyl-1,2-benzisoxazol-3(2H)-one
6-methyl-2-trityl-1,2-benzoxazol-3(2H)-on
6-methyl-2-trityl-1,2-benzoxazol-3(2H)-one
diphenylmethyl(2R)-3-methyl-2-[(1R,5S)-3-(4-methylphenyl)-7-oxo-4-oxa-2,6-diazabicyclo[3.2.0]hept-2-en-6-yl]but-3-enoat
diphenylmethyl(2R)-3-methyl-2-[(1R,5S)-3-(4-methylphenyl)-7-oxo-4-oxa-2,6-diazabicyclo[3.2.0]hept-2-en-6-yl]but-3-enoate
DNA (syntetisk plasmidvektor pCOR, som udtrykker et fusionsprotein af humant interferon beta signalpeptid og 21-154 af human sur fibroblast-vækstfaktor)
DNA (synthetic plasmid vector pCOR human interferon beta signal peptide fusion protein with 21-154-human acidic fibroblast growth factor-specifying)
methyl-(5R,7S,10S)-10-tert-butyl-15,15-dimethyl-3,9,12-trioxo-6,7,9,10,11,12,14,15,16,17,18,19-dodecahydro-1H,5H-2,23:5,8-dimethano-4,13,2,8,11-benzodioxatriazacyclohenicosin-7(3H)-carboxylat
methyl (5R,7S,10S)-10-tert-butyl-15,15-dimethyl-3,9,12-trioxo-6,7,9,10,11,12,14,15,16,17,18,19-dodecahydro-1H,5H-2,23:5,8-dimethano-4,13,2,8,11-benzodioxatriazacyclohenicosine-7(3H)-carboxylate
methyl-3-(chlorsulfonyl)thiophen-2-carboxylat
methyl 3-(chlorosulfonyl)thiophene-2-carboxylate
methyl-3-[5-[4-(cyclopentyloxy)-2-hydroxybenzoyl]-2-[(2-triphenylmethyl-1,2-benzisoxazol-3(2H)-on- 6-yl)methoxy]phenyl]propionat
methyl 3-[5-[4-(cyclopentyloxy)-2-hydroxybenzoyl]-2-[(2-triphenylmethyl-1,2-benzisoxazol-3(2H)-on-6-yl)methoxy]phenyl]propionate
methyl-3-amino-4-methylthiophen-2-carboxylat
methyl 3-amino-4-methylthiophene-2-carboxylate
N-(5-chlor-1,3-benzodioxol-4-yl)-7-[2-(4-methyl-1-piperazinyl)ethoxy]-5-[(tetrahydro-2H-pyran-4-yl)oxy]-4-quinazolinamin – (2E)-2-butendioat (1:2)
N-(5-chloro-1,3-benzodioxol-4-yl)-7-[2-(4-methyl-1-piperazinyl)ethoxy]-5-[(tetrahydro-2H-pyran-4-yl)oxy]-4-quinazolinamine – (2E)-2-butenedioate (1:2)
N,N′,N′′-(boroxin-2,4,6-triyltris[(1S)-3-methylbutan-1,1-diyl]imino[(2S)-1-oxo-3-phenylpropan-1,2-diyl])tripyrazin-2-carboxamid
N,N′,N′′-(boroxin-2,4,6-triyltris[(1S)-3-methylbutane-1,1-diyl]imino[(2S)-1-oxo-3-phenylpropane-1,2-diyl])tripyrazine-2-carboxamide
N-[4-(4-fluorbenzyl)morpholin-2-yl]methylacetamid
N-[4-(4-fluorobenzyl)morpholin-2-yl]methylacetamide
S-[(1R,3S)-1-oxidotetrahydrothiophen-3-yl] ethanthioat
S-[(1R,3S)-1-oxidotetrahydrothiophen-3-yl] ethanethioate
(1R,2R)-1-[(cyclopropylsulfonyl)carbamoyl]-2-ethylcyclopropanaminium-4-methylbenzensulfonat
(1R,2R)-1-[(cyclopropylsulfonyl)carbamoyl]-2-ethylcyclopropanaminium 4-methylbenzenesulfonate
(2R)-3-(benzylsulfanyl)-N-[(2S)-1-[(2S,3S)-1-hydrazinyl-3-methyl-1-oxopentan-2-yl]amino-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]-2-[(4-methylphenyl)sulfonyl]aminopropanamid
(2R)-3-(benzylsulfanyl)-N-[(2S)-1-[(2S,3S)-1-hydrazinyl-3-methyl-1-oxopentan-2-yl]amino-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]-2-[(4-methylphenyl)sulfonyl]aminopropanamide
1-[(4-methylphenyl)sulfonyl]-1,2,3,4-tetrahydro-5H-1-benzazepin-5-on
1-[(4-methylphenyl)sulfonyl]-1,2,3,4-tetrahydro-5H-1-benzazepin-5-one
2-(cyclohexylmethyl)-N-2-[(2S)-1-methylpyrrolidin-2-yl]ethyl-1,2,3,4-tetrahydroisoquinolin-7-sulfonamid-di[(2E)-but-2-endioat]-hydrat
2-(cyclohexylmethyl)-N-2-[(2S)-1-methylpyrrolidin-2-yl]ethyl-1,2,3,4-tetrahydroisoquinoline-7-sulfonamide di[(2E)-but-2-enedioate] hydrate
3-[(methylsulfonyl)amino]-2-phenyl-N-[(1S)-1-phenylpropyl]quinolin-4-carboxamid
3-[(methylsulfonyl)amino]-2-phenyl-N-[(1S)-1-phenylpropyl]quinoline-4-carboxamide
7-chlor-1-[(4-methylphenyl)sulfonyl]-1,2,3,4-tetrahydro-5H-1-benzazepin-5-on
7-chloro-1-[(4-methylphenyl)sulfonyl]-1,2,3,4-tetrahydro-5H-1-benzazepin-5-one
N-(5-methoxy-2-phenoxyphenyl)methansulfonamid
N-(5-methoxy-2-phenoxyphenyl)methanesulfonamide
N-[4-(N-formylglycyl)-5-hydroxy-2-phenoxyphenyl]methansulfonamid
N-[4-(N-formylglycyl)-5-hydroxy-2-phenoxyphenyl]methanesulfonamide
N-[4-(N-formylglycyl)-5-methoxy-2-phenoxyphenyl]methansulfonamid
N-[4-(N-formylglycyl)-5-methoxy-2-phenoxyphenyl]methanesulfonamide
N-2-[(4-hydroxyphenyl)amino]pyridin-3-yl-4-methoxybenzensulfonamidhydrochlorid
N-2-[(4-hydroxyphenyl)amino]pyridin-3-yl-4-methoxybenzenesulfonamide hydrochloride
N-5-[(diphenylphosphoryl)methyl]-4-(4-fluorphenyl)-6-(propan-2-yl)pyrimidin-2-yl-N-methylmethansulfonamid
N-5-[(diphenylphosphoryl)methyl]-4-(4-fluorophenyl)-6-(propan-2-yl)pyrimidin-2-yl-N-methylmethanesulfonamide
(4S)-4-ethyl-4-hydroxy-1H-pyrano[3′,4′:6,7]indolizino[1,2-b]quinolin-3,14(4H,12H)-dion
(4S)-4-ethyl-4-hydroxy-1H-pyrano[3′,4′:6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione
colchicosid
colchicoside
2-(4-methoxybenzyl)thiophen-3-yl-β-D-glucopyranosid
2-(4-methoxybenzyl)thiophen-3-yl β-D-glucopyranoside
(6R,7R)-7-(N-[(4-ethyl-2,3-dioxopiperazin-1-yl)carbonyl]-D-threonylamino)-3-[(1-methyl-1H-tetrazol-5-yl)sulfanyl]methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-en-2-carboxylsyre
(6R,7R)-7-(N-[(4-ethyl-2,3-dioxopiperazin-1-yl)carbonyl]-D-threonylamino)-3-[(1-methyl-1H-tetrazol-5-yl)sulfanyl]methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
poly(oxy-1,2-ethandiyl), α-hydro-ω-methoxy, diester med 21N6, 21’N6-[[(N2, N6-dicarboxy-L-lysyl-β-alanyl)imino]bis(1-oxo-2, 1-ethandiyl)]bis[N-acetylglycyl-L-leucyl-L-tyrosyl-L-alanyl-L-cysteinyl-L-histidyl-L-methionylglycyl-L-prolyl-L-isoleucyl-L-threonyl-3-(1-naphthalenyl)-L-alanyl-L-valyl-L-cysteinyl-L-glutaminyl-L-prolyl-L-leucyl-L-arginyl-N-methylglycyl-L-lysinamid] cyklisk (6→15), (6’→15’) bis(disulfid)
poly(oxy-1,2-ethanediyl), α-hydro-ω-methoxy, diester with 21N6, 21′N6-[[(N2, N6-dicarboxy-L-lysyl-β-alanyl)imino]bis(1-oxo-2, 1-ethanediyl)]bis[N-acetylglycyl-L-leucyl-L-tyrosyl-L-alanyl-L-cysteinyl-L-histidyl-L-methionylglycyl-L-prolyl-L-isoleucyl-L-threonyl-3-(1-naphthalenyl)-L-alanyl-L-valyl-L-cysteinyl-L-glutaminyl-L-prolyl-L-leucyl-L-arginyl-N-methylglycyl-L-lysinamide] cyclic (6→15), (6′→15′) bis(disulfide)
Liste over farmaceutiske mellemstoffer, dvs. stoffer, der bruges til fremstilling af farmaceutiske færdigvarer, der skal slettes på listen over produkter, der er fritaget for told, i bilag 6 til bilag I til forordning (EØF) nr. 2658/87, fordi de overføres til listen over produkter, der er fritaget for told, i bilag 3 til bilag I i forordning (EØF) 2658/87
List of pharmaceutical intermediates, i.e. compounds used for the manufacture of finished pharmaceutical products, to be withdrawn from the list of products receiving duty-free treatment included in Annex 6 to Annex I to Regulation (EEC) No 2658/87 due to their transfer to the list of products receiving duty-free treatment included in Annex 3 to Annex I to Regulation (EEC) No 2658/87
se anecortav (INN)
see anecortave (INN)
4-(nitrooxy)butyl-(2S)-2-(6-methoxy-2-naphthyl)propanoat
4-(nitrooxy)butyl (2S)-2-(6-methoxy-2-naphthyl) propanoate
se naproxcinod (INN)
see naproxcinod (INN)
se carisbamat (INN)
see carisbamate (INN)
se levamlodipin (INN)
see levamlodipine (INN)
se axitinib (INN)
see axitinib (INN)
N-(2-chlor-6-methylphenyl)-2-(6-[4-(2-hydroxyethyl)piperazin-1-yl]-2-methylpyrimidin-4-ylamino)thiazol-5-carboxamid
N-(2-chloro-6-methylphenyl)-2-(6-[4-(2-hydroxyethyl)piperazin-1-yl]-2-methylpyrimidin-4-ylamino)thiazole-5-carboxamide
se dasatinib (INN)
see dasatinib (INN)
se emtricitabin (INN)
see emtricitabine(INN)
se esreboxetin (INN)
see esreboxetine (INN)
(2S)-2-methoxy-3-4-[2-(5-methyl-2-phenyl-1,3-oxazol-4-yl)ethoxy]-1-benzothiophen-7-ylpropansyre
(2S)-2-methoxy-3-4-[2-(5-methyl-2-phenyl-1,3-oxazol-4-yl)ethoxy]-1-benzothiophen-7-ylpropanoic acid
se aleglitazar (INN)
see aleglitazar (INN)
2-(2-furyl)-7-(2-4-[4-(2-methoxyethoxy)phenyl]piperazin-1-ylethyl)-7H-pyrazolo[4,3-e][1,2,4]triazolo[2,3-c]pyrimidin-5-amin
2-(2-furyl)-7-(2-4-[4-(2-methoxyethoxy)phenyl] piperazin-1-ylethyl)-7H-pyrazolo[4,3-e][1,2,4]triazolo[2,3-c]pyrimidin-5-amine
se preladenant (INN)
see preladenant (INN)
se trelanserin (INN)
see trelanserin (INN)
se dexelvucitabin (INN)
see dexelvucitabine (INN)
se raltegravir (INN)
see raltegravir (INN)
se mavacoxib (INN)
see mavacoxib (INN)
se zibotentan (INN)
see zibotentan (INN)
En fjerde revision blev skønnet nødvendig og blev iværksat i 2009.
A fourth review was deemed appropriate and was launched in 2009.
Det blev konkluderet, at der bør indrømmes behandling med toldfritagelse af yderligere et bestemt antal INN og farmaceutiske mellemstoffer, der bruges til produktion og fremstilling af farmaceutiske færdigvarer, at nogle af disse mellemstoffer, der allerede er tilføjet i det farmaceutiske sektorarrangement med efterfølgende ændringer, bør overføres til listen over INN, og at listen over nærmere bestemte præfikser og suffikser for salte, estere eller hydrater af INN bør udvides.
It concluded that a certain number of additional INNs and pharmaceutical intermediates used for the production and manufacture of finished pharmaceuticals should be granted duty-free treatment, that some of those intermediates already included in the pharmaceutical sectoral arrangement and its revisions should be transferred to the list of INNs, and that the list of specified prefixes and suffixes for salts, esters or hydrates of INNs should be expanded.
Rådets forordning (EU) nr. 1239/2010
Council Regulation (EU) No 1239/2010
om tilpasning med virkning fra den 1. juli 2010 af vederlag og pensioner til tjenestemænd og øvrige ansatte ved Den Europæiske Union samt af justeringskoefficienterne for disse vederlag og pensioner
adjusting with effect from 1 July 2010 the remuneration and pensions of officials and other servants of the European Union and the correction coefficients applied thereto
under henvisning til vedtægten for tjenestemænd i De Europæiske Fællesskaber og ansættelsesvilkårene for de øvrige ansatte i Fællesskaberne som fastsat ved Rådets forordning (EØF, Euratom, EKSF) nr. 259/68 [1], særlig artikel 63, 64, 65 og 82 i tjenestemandsvedtægten og bilag VII, XI og XIII til tjenestemandsvedtægten og artikel 20, stk. 1, artikel 64, 92 og 132 i ansættelsesvilkårene for de øvrige ansatte,
Having regard to the Staff Regulations of Officials and the Conditions of Employment of Other Servants of the European Communities laid down by Regulation (EEC, Euratom, ECSC) No 259/68 [1], and in particular Articles 63, 64, 65 and 82 of the Staff Regulations and Annexes VII, XI and XIII thereto, and Articles 20(1), 64, 92 and 132 of the Conditions of Employment of Other Servants,
under henvisning til forslag fra Europa-Kommissionen, og ud fra følgende betragtning:
Having regard to the proposal from the European Commission,
For at sikre tjenestemændene og de øvrige ansatte ved Den Europæiske Union en købekraftsudvikling, der er parallel med udviklingen for de nationale tjenestemænd i medlemsstaterne, bør der foretages en tilpasning af vederlag og pensioner for tjenestemænd og øvrige ansatte ved Den Europæiske Union på grundlag af den årlige undersøgelse i 2010 —
Whereas in order to guarantee that the purchasing power of Union officials and other servants develops in parallel with that of national civil servants in the Member States, the remuneration and pensions of officials and other servants of the European Union should be adjusted under the 2010 annual review,
Med virkning fra den 1. juli 2010 ændres datoen »den 1. juli 2009« til »den 1. juli 2010« i tjenestemandsvedtægtens artikel 63, stk. 2.
With effect from 1 July 2010, the date ‘1 July 2009’ in the second paragraph of Article 63 of the Staff Regulations shall be replaced by ‘1 July 2010’.
Med virkning fra den 1. juli 2010 udskiftes i tjenestemandsvedtægtens artikel 66 den tabel over den månedlige grundløn, som danner grundlag for beregningen af vederlag og pensioner, med følgende tabel:
With effect from 1 July 2010 the table of basic monthly salaries in Article 66 of the Staff Regulations applicable for the purposes of calculating remuneration and pensions shall be replaced by the following: